AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8677154
Drug: Plasma antioxidant
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma antioxidant activity (AOA) during clinical treatment (induction of chemotherapy, surgery, radiotherapy, maintenance chemotherapy)
Trial: 2186259
Drug: Veramex 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veramex 80 (80 mg non-retarded Verapamil)
Trial: 2186259
Drug: Reference substance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference substance (80 mg non-retarded Verapamil)
Trial: 386125
Drug: Cimetidine, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 1 g daily over eight weeks
Trial: 28124478
Drug: Rifapentine (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifapentine (1200 mg daily)
Trial: 25712967
Drug: 15-μg dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15-μg dose of A/H5N1/Indonesia/05/05 (clade 2) vaccine
Trial: 25712967
Drug: 90-μg dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90-μg dose of A/H5N1/Indonesia/05/05 (clade 2) vaccine
Trial: 25712967
Drug: Low-dose priming
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose priming with mismatched pandemic influenza A(H5N1) vaccine
Trial: 20192708
Drug: Hormone treatment
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone treatment with drospirenone 2 mg + estradiol emidrate 1 mg for 6 months
Trial: 17854239
Drug: Longer time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longer time to all-cause treatment discontinuation
Trial: 15491558
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (800 mcg)
Trial: 9246650
Drug: Affect-management treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Affect-management treatment group (n = 17)
Trial: 8297916
Drug: FeSO4 (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FeSO4 (60 or 120 mg Fe/d)
Trial: 2436092
Drug: Amitriptyline (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (up to 150 mg nightly)
Trial: 25323621
Drug: Aztreonam for
RxNorm normalized name: Aztreonam for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aztreonam for inhalation solution (AZLI)
Trial: 19351876
Drug: valsartan treatment
RxNorm normalized name: Valsartan
DrugBank: Valsartan (DB00177)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: valsartan treatment for 90 days
Trial: 15526247
Drug: ACE inhibitor,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitor, captopril
Trial: 8366821
Drug: IVIG (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG (250 mg/Kg on the first and seventh day after admission)
Trial: 26537570
Drug: Regular telephone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular telephone calls every 2 weeks and weekly text messages for 6 months (intervention group)
Trial: 23010790
Drug: Antibiotics (amoxicillin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotics (amoxicillin with clavulanic acid) for 5 days
Trial: 20086017
Drug: Chemokine receptor
RxNorm normalized name: Chemokine receptor antagonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemokine receptor 1 antagonist BX 471
Trial: 16820546
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR (150 mg twice per day)
Trial: 7745771
Drug: Accelerated recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated recombinant tissue‐type plasminogen activator (rt‐PA) plus IV heparin
Trial: 7745771
Drug: Streptokinase plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase plus either subcutaneous or intravenous (IV) heparin
Trial: 7745771
Drug: Combined streptokinase
RxNorm normalized name: streptokinase, combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined streptokinase and rt‐PA plus IV heparin
Trial: 2203214
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (medical gymnastics)
Trial: 7019293
Drug: Rinkel injection
RxNorm normalized name: Absidia capillata 0.076 g in 20 mL / ACROTHECIUM ROBUSTUM 0.077 g in 20 mL / MICROSPORUM AUDOUINII 0.077 g in 20 mL / MICROSPORUM CANIS 0.077 g in 20 mL / APIOSPORA MONTAGNEI 0.077 g in 20 mL / PHYCOMYCES BLAKESLEEANUS 0.077 g in 20 mL / SPOROTRICHUM PRUINOSUM 0.077 g in 20 mL / STACHYBOTRYS CHARTARUM 0.077 g in 20 mL / SYNCEPHALASTRUM RACEMOSUM 0.077 g in 20 mL / TETRACOCCOSPORIUM PAXIANUM 0.077 g in 20 mL / VERTICILLIUM ALBO-ATRUM 0.077 g in 20 mL / THERMOMYCES LANUGINOSUS 0.077 g in 20 mL / Trichosporon cutaneum 0.077 g in 20 mL SUBCUTANEOUS INJECTION, SOLUTION [RINKEL MOLD MIX C]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rinkel injection therapy (RIT)
Trial: 30085324
Drug: Adalimumab (active
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab (active treatment)
Trial: 24905929
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) - GaAlAs diode laser [780 nm, 30 mW continuous wave (CW), 0.785 cm(2), 38.2 mW/cm(2)], applied for 90 sec per point, 5 times per week for 2 weeks, followed by 10 treatments every other day for 3 weeks (total of 20 treatments)
Trial: 24905929
Drug: Placebo (sham)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sham) laser treatment
Trial: 18793528
Drug: Cinacalcet administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet administered with the first major meal after dialysis
Trial: 18793528
Drug: Cinacalcet administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet administered with food during the dialysis session
Trial: 11797179
Drug: lamivudine-zidovudine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamivudine-zidovudine (150 mg/300 mg) combination tablet and one 300-mg abacavir tablet administered twice daily
Trial: 8129119
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% with adrenaline 5 micrograms.ml‐1 (dose 40 mg)
Trial: 2628746
Drug: meat vegetable
RxNorm normalized name: Hydrogenated Vegetable Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meat vegetable dinner fortified with iron‐2‐sulfate (3 mg iron per 100 kcal)
Trial: 2628746
Drug: milk based
RxNorm normalized name: milk based formulas
FDA approved: no
EMA approved: no
PMDA approved: no
Description: milk based rice cereal (MBRC) fortified with iron‐3‐pyrophosphate (3 mg iron per 100 kcal)
Trial: 31000477
Drug: VRC01 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VRC01 (40 mg/kg) intravenously every 3 weeks for up to 24 weeks during analytic interruption of ART
Trial: 26487008
Drug: Glucose ingestion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose ingestion (1.7 g/min)
Trial: 26487008
Drug: Sucrose ingestion
RxNorm normalized name: Sucrose
DrugBank: Sucrose (DB02772)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucrose ingestion (1.7 g/min)
Trial: 18573809
Drug: Inhalation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation treatment through a face mask
Trial: 16720496
Drug: Cytostatic drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytostatic drug treatment close to surgery
Trial: 15587929
Drug: Teicoplanin (TEI)
RxNorm normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin (TEI) administered with three 10 mg/kg Q12h loading infusions, and maintenance with 10 mg/kg or 15 mg/kg Q24h
Trial: 11412732
Drug: Intradural-epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradural-epidural analgesia (IEA) - 25 microgram of intradural fentanyl with 2.5 mg of isobaric bupivacaine with adrenalin, followed by 8 mL bolus of 0.125% bupivacaine at 8 ml/h
Trial: 11412732
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural analgesia (CEA) - 8 ml of 0.25% bupivacaine with adrenalin, followed by perfusion of 0.125% bupivacaine and 1 microgram/ml of fentanyl at 8 ml/h
Trial: 7705386
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg 17 beta-oestradiol
Trial: 2651054
Drug: Chronic magnesium
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic magnesium supplementation (2 g/day)
Trial: 22280901
Drug: Aged garlic
RxNorm normalized name: Garlic 600 MG Oral Tablet [KYOLIC AGED GARLIC EXTRACT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aged garlic extract (2.56 g/d)
Trial: 20374102
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment based on TCM pattern diagnosis
Trial: 15767619
Drug: L-thyroxine, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine, 100 microg/d (standard treatment)
Trial: 15767619
Drug: L-thyroxine, 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine, 75 microg/d plus liothyronine, 5 microg/d (combination treatment)
Trial: 15767619
Drug: L-thyroxine, 87.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-thyroxine, 87.5 microg/d plus liothyronine, 7.5 microg/d (add-on combination treatment)
Trial: 10570752
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human interleukin-3 (rhIL-3) administered subcutaneously at a dose of 5 micrograms/kg once a day for 10 days starting from day 4 of chemotherapy
Trial: 10570752
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human interleukin-3 (rhIL-3) administered subcutaneously at a dose of 10 micrograms/kg once a day for 10 days starting from day 4 of chemotherapy
Trial: 10570752
Drug: Control observation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control observation period (no rhIL-3 administration)
Trial: 2370107
Drug: Pnu-Imune (23-valent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pnu-Imune (23-valent pneumococcus vaccine)
Trial: 517882
Drug: Delta-9-tetrahydrocannabinol (THC),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delta-9-tetrahydrocannabinol (THC), 15 mg orally three times a day
Trial: 517882
Drug: Prochlorperazine, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine, 10 mg orally three times a day
Trial: 9156374
Drug: Dichloroacetate (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dichloroacetate (50 mg/kg) administered via 30-minute intravenous infusion
Trial: 8395087
Drug: Hyperfractionated radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiotherapy (1.3 Gy twice daily for five weeks, total dose 65 Gy)
Trial: 8395087
Drug: Conventional radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional radiotherapy (2.0 Gy daily for six weeks, total dose 60 Gy)
Trial: 2441166
Drug: Transdermal clonidine
RxNorm normalized name: clonidine Transdermal System
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal clonidine patches (2.5 mg)
Trial: 16170291
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with DRNA 5 mg vaginal suppositories for 15 days monthly, reduced gradually thereafter
Trial: 8772549
Drug: Acipimox (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (250 mg orally at -270 min and 250 mg at -60 min)
Trial: 8772549
Drug: Acipimox with
RxNorm normalized name: acipimox
DrugBank: Acipimox (DB09055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox with Pyridostigmine (120 mg orally at -60 min)
Trial: 1728249
Drug: m-chlorophenylpiperazine (m-CPP;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-chlorophenylpiperazine (m-CPP; 0.5 mg/kg orally)
Trial: 1728249
Drug: fenfluramine hydrochloride
RxNorm normalized name: fenfluramine hydrochloride
DrugBank: Fenfluramine (DB00574)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fenfluramine hydrochloride (60 mg orally)
Trial: 30431004
Drug: Edoxaban 15
RxNorm normalized name: edoxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 15 mg daily for 1 week (n = 93)
Trial: 30431004
Drug: Edoxaban 15
RxNorm normalized name: edoxaban 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban 15 mg daily for 2 weeks (n = 109)
Trial: 15357156
Drug: IV administration
RxNorm normalized name: IV Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV administration set changed on day 4 (n = 203)
Trial: 15357156
Drug: IV administration
RxNorm normalized name: IV Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV administration set not changed (n = 201)
Trial: 9727728
Drug: SSRI (paroxetine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRI (paroxetine) + augmenting agent (pindolol)
Trial: 8053578
Drug: ACEI therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACEI therapy stopped the evening before surgery (either enalapril or captopril)
Trial: 3197373
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion (0.27 nmol (50 ng) min‐1 kg‐1)
Trial: 26323043
Drug: Antidepressant medication
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant medication with clinical management
Trial: 23599435
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg tabalumab
Trial: 18665938
Drug: Amoxicillin 1000
RxNorm normalized name: amoxicillin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 1000 mg with clarithromycin 500 mg and omeprazole 20 mg twice daily for 2 weeks (BID group, n = 93)
Trial: 18665938
Drug: Amoxicillin 500
RxNorm normalized name: amoxicillin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 500 mg four times daily with clarithromycin 500 mg and omeprazole 20 mg twice daily for 2 weeks (QID group, n = 93)
Trial: 15962678
Drug: Colloids (Haemaccel)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colloids (Haemaccel) 10 ml/Kg before positioning
Trial: 10501745
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of nitric oxide (INO) at 1-40 ppm for up to 30 days or until an endpoint was reached.
Trial: 10501745
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment with inhaled nitric oxide (INO)
Trial: 10501745
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of nitric oxide (INO)
Trial: 10501745
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment without inhaled nitric oxide (INO)
Trial: 8951777
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day aspirin
Trial: 7074822
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (propylene and polyethylene glycol, saline)
Trial: 23524525
Drug: Pioglitazone 15
RxNorm normalized name: pioglitazone 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 15 mg twice a day
Trial: 23524525
Drug: Glibenclamide 5
RxNorm normalized name: glibenclamide 5 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide 5 mg twice a day
Trial: 23524525
Drug: Rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 5 mg added after 6 months
Trial: 21330267
Drug: Older age
RxNorm normalized name: AGS-499
DrugBank: AGS-499 (DB18058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older age and belief in treatment effectiveness
Trial: 15691552
Drug: Topical 0.02%
RxNorm normalized name: tretinoin topical 0.02% topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.02% mitomycin C
Trial: 15691552
Drug: Corticosteroid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid treatment (fluorometholone sodium 2%)
Trial: 10795802
Drug: Visual Manipulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Visual Manipulation Test (VMT) administered to children
Trial: 1676394
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 0.25 mg (IB)
Trial: 1676394
Drug: Terbutalin 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutalin 2.5 mg (TER)
Trial: 1676394
Drug: Sequential inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential inhalation of IB after TER
Trial: 1676394
Drug: Sequential inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential inhalation of TER after IB
Trial: 1676394
Drug: Both agents
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both agents (IB and TER)
Trial: 6605370
Drug: PABA ester‐oxybenzone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PABA ester‐oxybenzone preparation
Trial: 24512496
Drug: DHEA (130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (130 mg for 5 days)
Trial: 22678971
Drug: Internet-based cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based cognitive-behavioral intervention, 45 minutes, twice weekly for 5 weeks
Trial: 15918384
Drug: Hydroxyethyl starch
RxNorm normalized name: Hydroxyethyl starch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl starch 500 mL
Trial: 15918384
Drug: Gelatine 500
RxNorm normalized name: Gelatine
DrugBank: Gelatin (DB11242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelatine 500 mL
Trial: 12707718
Drug: Oral eniluracil
RxNorm normalized name: Eniluracil
DrugBank: Eniluracil (DB03516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral eniluracil (EU) 20 mg plus LV 30 mg on days 1-3 with a single dose of 5-FU 15-29 mg/m2 on day 2
Trial: 12707718
Drug: Leucovorin (LV)
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Leucovorin (LV) 30 mg on days 1-2 with a single dose of EU at least 1 h prior to 5-FU 29 mg/m2 on day 2 weekly for 3 of 4 weeks
Trial: 12707718
Drug: 5-FU 2300
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU 2300 mg/m2 as a pharmacokinetic reference
Trial: 10655927
Drug: Cisatracurium 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium 0.1 mg kg‐1
Trial: 2060339
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of inhaled verapamil
Trial: 2060339
Drug: Highest dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highest dose of verapamil tolerated (20 to 160 mg)
Trial: 6339939
Drug: True plasmapheresis
RxNorm normalized name: HAEMO-PAK UNIT FOR PLASMAPHERESIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: True plasmapheresis therapy
Trial: 6339939
Drug: Sham plasmapheresis
RxNorm normalized name: HAEMO-PAK UNIT FOR PLASMAPHERESIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham plasmapheresis therapy
Trial: 30268162
Drug: Aloe Vera
RxNorm normalized name: ALOE VERA
DrugBank: Aloe vera leaf (DB13906)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aloe Vera gel applied twice a day on hip, sacrum, and heel
Trial: 30268162
Drug: Placebo (gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (gel of water and starch)
Trial: 26370072
Drug: Dental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental treatment for dental caries
Trial: 25249234
Drug: Ceylon cinnamon
RxNorm normalized name: Ceylon Cinnamon Plus Biotin And Chromium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceylon cinnamon hydro‐alcoholic extract (CCE) 1 g
Trial: 17268082
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (100 mg), riboflavin (10 mg), niacin (50 mg) along with tamoxifen (10 mg twice a day) for 45 days
Trial: 17268082
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (100 mg), riboflavin (10 mg), niacin (50 mg) along with tamoxifen (10 mg twice a day) for 90 days
Trial: 17268082
Drug: Tamoxifen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen therapy alone for more than 1 year
Trial: 16119478
Drug: Fluvoxamine (l
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (l allele)
Trial: 12394789
Drug: Stavudine (d4T)
RxNorm normalized name: STAVUDINE (d4T)
DrugBank: Stavudine (DB00649)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stavudine (d4T) monotherapy
Trial: 7763068
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone treatment (Genotropin 30 IU/m2/week)
Trial: 2279745
Drug: Alclometasone dipropionate
RxNorm normalized name: Alclometasone Dipropionate
DrugBank: Alclometasone (DB00240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alclometasone dipropionate cream 0.1%